4.7 Article

Genetic module and miRNome trait analyses reflect the distinct biological features of endothelial progenitor cells from different anatomic locations

期刊

BMC GENOMICS
卷 13, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1471-2164-13-447

关键词

-

资金

  1. National Science Council (NSC) [NSC101-2320-B-010-059-MY3, NSC98-2320-B-010-020-MY3, NSC100-2627-B-010-007]
  2. Tri-Service General Hospital [TSGH-C102-027]
  3. Yen Tjing Lin Medical Foundation [CI-100-23]
  4. Mackay Memorial Hospital [MMH-HB-100-01]
  5. Taipei Veteran General Hospital [V101E2-008]
  6. Taipei Veteran General Hospital (Cancer Excellence Center Plan) [DOH101-TD-C-111-007]
  7. National Yang-Ming University (Ministry of Education, Aim for the Top University Plan)
  8. UST-UCSD International Center for Excellence in Advanced Bioengineering
  9. Taiwan NSC I-RiCE Program [NSC100-2911-I-009-101]

向作者/读者索取更多资源

Background: Endothelial progenitor cells (EPCs) play a fundamental role in post-natal vascular repair, yet EPCs from different anatomic locations possess unique biological properties. The underlying mechanisms are unclear. Results: EPCs from CB expressed abundant genes involved in cell cycle, hypoxia signalling and blood vessel development, correlating with the phenotypes that CB-EPCs proliferated more rapidly, migrated faster, and formed tubule structure more efficiently. smRNA-seq further deciphered miRNome patterns in EPCs isolated from CB or PB: 54 miRNAs were enriched in CB-EPCs, while another 50 in PB-EPCs. Specifically, CB-EPCs expressed more angiogenic miRNAs such as miR-31, while PB-EPCs possessed more tumor suppressive miRNAs including miR-10a. Knocking down miR-31 levels in CB-EPCs suppressed cell migration and microtubule formation, while overexpressing miR-31 in PB-EPCs helped to recapitulate some of CB-EPC functions. Conclusions: Our results show the foundation for a more detailed understanding of EPCs from different anatomic sources. Stimulating the expression of angiogenic microRNAs or genes in EPCs of low activity (such as those from patients with cardiovascular diseases) might allow the development of novel therapeutic strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据